This report from the Bloomberg Pharmaceutical Law and Industry Report on State Pharmacy Boards and the principal of “self-regulation”. The author points out that, for example, pharmacy board oversight of the actual manufacture of prescription drugs or even the management of employer provided drug benefit plans, are activities beyond the realm of self regulation. The author’s conclusion can be summarized in that state pharmacy boards should be reformed to confine their authority solely to self regulating the competency and behavior of pharmacists and any jurisdiction over activities or business beyond the realm of self regulation should be retracted.